Many studies have reported that the number of tumor-infiltrating T cells that express checkpoint molecules such as PD-1, CTLA-4, and Lag-3 is a reliable prognostic marker in lung cancer and immune checkpoint therapy has served as an effective treatment strategy for LUAD 38, 39. Here, CTLA4 is linked to lung cancer.